Neurocrine Biosciences Inc vs Super Micro Computer Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Super Micro Computer Inc trades at $30.02 (market cap $15.41B). The key difference: Neurocrine Biosciences Inc and Super Micro Computer Inc are close in size by market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Super Micro Computer Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | SMCI | |
|---|---|---|
Market Cap | $17.40B | $15.41B |
Sector | Health | Technology |
52-Week High | $180.55 | $60.71 |
52-Week Low | $123.10 | $20.53 |
Enterprise Value | $16.49B | $22.93B |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →